The Role of the NO Axis and its Therapeutic Implications in Pulmonary Arterial Hypertension

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Heart Failure Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1023/A:1022150819223PMID 12652155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dichloroacetate, a Metabolic Modulator, Prevents and Reverses Chronic Hypoxic Pulmonary Hypertension in Rats: Role of Increased Expression and Activity of Voltage-Gated Potassium Channels

  2002cited by this paper
• Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide

  2002cited by this paper
• Diversity in Mitochondrial Function Explains Differences in Vascular Oxygen Sensing

  2002cited by this paper
• Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome.

  2002cited by this paper
• The pathobiology of pulmonary hypertension: Smooth muscle cells and ion channels

  2001cited by this paper
• Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1.

  2001cited by this paper
• Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension

  2001influential reference
• On-demand IC351 (Cialis™) enhances erectile function in patients with erectile dysfunction

  2001cited by this paper
• Inhibition of lung phosphodiesterase improves responsiveness to inhaled nitric oxide in isolated-perfused lungs from rats challenged with endotoxin

  2001cited by this paper
• Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil.

  2001cited by this paper
• New and experimental therapies for pulmonary hypertension.

  2001cited by this paper
• Potassium Channels in Cardiovascular Biology

  2001cited by this paper
• Role for Endothelin-1-Induced Superoxide and Peroxynitrite Production in Rebound Pulmonary Hypertension Associated With Inhaled Nitric Oxide Therapy

  2001influential reference
• Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension

  2001cited by this paper
• -OONO: rebounding from nitric oxide.

  2001influential reference
• The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channels.

  2001cited by this paper
• Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension.

  2001cited by this paper
• Anorectic drugs and pulmonary hypertension from the bedside to the bench.

  2001cited by this paper
• Sympathetic activation by sildenafil.

  2001cited by this paper
• The NO donor molsidomine reduces endothelin-1 gene expression in chronic hypoxic rat lungs.

  2001influential reference
• The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

  2001cited by this paper
• Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension

  2001cited by this paper
• Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure

  2001cited by this paper
• Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

  2000influential reference
• Sympathetic Activation by Sildenafil

  2000cited by this paper
• eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia.

  2000cited by this paper
• Aerosol Gene Transfer With Inducible Nitric Oxide Synthase Reduces Hypoxic Pulmonary Hypertension and Pulmonary Vascular Remodeling in Rats

  2000cited by this paper
• Early abnormalities of pulmonary vascular development in the Fawn-Hooded rat raised at Denver's altitude.

  2000cited by this paper
• Mitochondria and Ca(2+)in cell physiology and pathophysiology.

  2000cited by this paper
• Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups.

  2000cited by this paper
• Interactions of oxidants with vascular signaling systems.

  2000influential reference
• Sildenafil in primary pulmonary hypertension.

  2000cited by this paper
• Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension.

  2000influential reference
• Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation.

  2000cited by this paper
• Hemodynamic effects of sildenafil in men with severe coronary artery disease.

  2000cited by this paper
• Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension.

  1999influential reference
• ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.

  1999cited by this paper
• NOS gene transfer inhibits expression of cell cycle regulatory molecules in vascular smooth muscle cells.

  1999cited by this paper
• Endothelin-1 is elevated in monocrotaline pulmonary hypertension.

  1999cited by this paper
• Inhaled nitric oxide: basic biology and clinical applications.

  1999cited by this paper
• Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.

  1999cited by this paper
• ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.

  1999cited by this paper
• The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia.

  1999cited by this paper
• Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat.

  1999cited by this paper
• Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension.

  1999cited by this paper
• Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension.

  1999cited by this paper
• Unaltered vasoconstrictor responsiveness after iNOS inhibition in lungs from chronically hypoxic rats.

  1999cited by this paper
• Nitric oxide synthase isoform expression in the developing lung epithelium.

  1999influential reference
• Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension.

  1999cited by this paper
• Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat.

  1999cited by this paper
• Endothelin-1 is elevated in monocrotaline pulmonary hypertension.

  1999cited by this paper
• Dexfenfluramine elevates systemic blood pressure by inhibiting potassium currents in vascular smooth muscle cells.

  1999cited by this paper
• Attenuated K+ channel gene transcription in primary pulmonary hypertension.

  1998cited by this paper
• Cyclic-GMP-Binding, Cyclic-GMP-Specific Phosphodiesterase (PDE5) Gene Expression Is Regulated during Rat Pulmonary Development

  1998cited by this paper
• Nitric Oxide Exposure Inhibits Endothelial NOS Activity But Not Gene Expression: A Role For Superoxide And Peroxynitrite • 1937

  1998cited by this paper
• Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.

  1998cited by this paper
• Role of inducible nitric oxide synthase in regulation of pulmonary vascular tone in the late gestation ovine fetus.

  1998cited by this paper
• Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

  1998cited by this paper
• Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension.

  1998cited by this paper
• Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung.

  1998cited by this paper
• Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system.

  1998cited by this paper
• Acceleration of Myosin Light Chain Dephosphorylation and Relaxation of Smooth Muscle by Telokin

  1998cited by this paper
• Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine.

  1998cited by this paper
• Mechanical loading regulates expression of talin and its mRNA, which are concentrated at myotendinous junctions.

  1998cited by this paper
• Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III)

  1998cited by this paper
• Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.

  1998influential reference
• Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: a role for superoxide.

  1998cited by this paper
• Measurement of NO and NO Synthase

  1998cited by this paper
• Models of persistent pulmonary hypertension of the newborn (PPHN) and the role of cyclic guanosine monophosphate (GMP) in pulmonary vasorelaxation.

  1997cited by this paper
• Genetic determinants of pulmonary hypertension in fawn-hooded rats.

  1997cited by this paper
• Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.

  1997influential reference
• Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene.

  1997cited by this paper
• Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension.

  1997influential reference
• Determination of Km for oxygen of nitric oxide synthase isoforms.

  1996cited by this paper
• Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle.

  1996cited by this paper
• Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats.

  1996cited by this paper
• Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.

  1996cited by this paper
• The hypotensive effect of L-arginine is associated with increased expired nitric oxide in humans.

  1996cited by this paper
• Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase

  1996cited by this paper
• A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

  1996cited by this paper
• Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.

  1996cited by this paper
• Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure.

  1996cited by this paper
• Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II.

  1996cited by this paper
• The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate.

  1996cited by this paper
• Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung.

  1996cited by this paper
• A comparison of inhaled nitric oxide with intravenous vasodilators in the assessment of pulmonary haemodynamics prior to cardiac transplantation.

  1996cited by this paper
• The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels

  1995cited by this paper
• Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension.

  1995cited by this paper
• Endothelinb Receptor Agonists Produce Pulmonary Vasodilation in Intact Newborn Lambs with Pulmonary Hypertension

  1995cited by this paper
• Constitutive endothelial nitric oxide synthase gene expression is regulated during lung development.

  1995cited by this paper
• Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide.

  1995cited by this paper
• Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

  1995cited by this paper
• A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter

  1995cited by this paper
• Acute hypoxic pulmonary vasoconstriction: a model of oxygen sensing.

  1995cited by this paper
• Inhaled nitric oxide therapy.

  1995cited by this paper
• Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment.

  1995cited by this paper
• Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

  1995cited by this paper
• Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation.

  1995cited by this paper
• Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia.

  1994cited by this paper
• Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure.

  1994cited by this paper

• Successful treatment of patent ductus arteriosus and severe pulmonary hypertension using sildenafil and beraprost sodium in two dogs

  2025cites this paper
• Potential Contribution of Carotid Body-Induced Sympathetic and Renin-Angiotensin System Overflow to Pulmonary Hypertension in Intermittent Hypoxia

  2019cites this paper
• Sildenafil for Pulmonary Arterial Hypertension.

  2019cites this paper
• Inhaled nebulized nitrite and nitrate therapy in a canine model of hypoxia-induced pulmonary hypertension.

  2019cites this paper
• The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension

  2018cites this paper
• Investigation of Phosphodiesterase 5 A ( PDE 5 A ) Inhibitors by Pharmacophore Modeling , Virtual Screening and Molecular Docking Approach

  2017cites this paper
• Идиопатическая легочная артериальная гипертензия: современный подход к диагностике и лекарственной терапии

  2017cites this paper
• Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension.

  2017cites this paper
• Successful Treatment of Suspected Pulmonary Arterial Hypertension in a Mealy Amazon Parrot (Amazona farinose)

  2016cites this paper
• Nitric Oxide (NO) and Hydrogen Sulfide (H2S): Molecular Targets for Vascular Muscle Relaxation

  2015cites this paper
• The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension

  2015cites this paper
• Idiopathic Pulmonary Arterial Hypertension

  2013cites this paper
• Acute effect of sildenafil on central hemodynamics in mechanically ventilated patients with WHO group III pulmonary hypertension and right ventricular failure necessitating administration of dobutamine.

  2013cites this paper
• Pulmonary Hypertension in Pregnancy

  2013cites this paper
• Aldosterone Inactivates the Endothelin-B Receptor via a Cysteinyl Thiol Redox Switch to Decrease Pulmonary Endothelial Nitric Oxide Levels and Modulate Pulmonary Arterial Hypertension

  2012cites this paper
• Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling.

  2011cites this paper
• Changes in arterial blood flow of free flaps after the administration of sildenafil in swine

  2011cites this paper
• Effects of sildenafil citrate on five dogs with Eisenmenger's syndrome.

  2011cites this paper
• Novel therapeutic approaches in pulmonary arterial hypertension: focus on tadalafil.

  2011cites this paper
• Nitrite Potently Inhibits Hypoxic and Inflammatory Pulmonary Arterial Hypertension and Smooth Muscle Proliferation via Xanthine Oxidoreductase–Dependent Nitric Oxide Generation

  2010cites this paper
• Role of Arginase in Sickle Cell Lung Disease and Hemolytic Anemias

  2010cites this paper
• Hypoxic upregulation of arginase II in human lung endothelial cells.

  2010cites this paper
• The dynamic regulation of microcirculatory conduit function: features relevant to transfusion medicine.

  2010cites this paper
• Effects of storage on the biology and clinical efficacy of the banked red blood cell.

  2010cites this paper
• Gene therapy techniques for the delivery of endothelial nitric oxide synthase to the lung for pulmonary hypertension.

  2010cites this paper
• Lung eNOS and iNOS are Reoxygenation Time‐Dependent Upregulated After Acute Hypoxia

  2010cites this paper
• Nitric oxide and pulmonary hypertension

  2010cites this paper
• First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

  2009cites this paper
• Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy

  2009cites this paper
• Gene therapies for pulmonary hypertension-from experimental trials to bedside aspects.

  2009cites this paper
• PDE5 inhibitors: in vitro and in vivo pharmacological profile.

  2009cites this paper
• Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern

  2009cites this paper
• Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.

  2008cites this paper
• Single‐Dose Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Stimulator BAY 63‐2521: An Ascending‐Dose Study in Healthy Male Volunteers

  2008cites this paper
• Gene transfer of endothelial nitric oxide synthase attenuates flow-induced pulmonary hypertension in rabbits.

  2008cites this paper
• 6 Phosphodiesterase-5 inhibitors in pulmonary arterial hypertension

  2008cites this paper
• Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.

  2008cites this paper
• Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.

  2007cites this paper
• Gene and stem cell therapy in the treatment of erectile dysfunction and pulmonary hypertension; potential treatments for the common problem of endothelial dysfunction.

  2007cites this paper
• Function of Kv 1 . 5 channels and genetic variations of KCNA 5 in patients with idiopathic pulmonary arterial hypertension

  2007cites this paper
• Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.

  2007cites this paper
• Phosphodiesterase type 5 inhibitors in the treatment and prevention of high altitude pulmonary edema.

  2007cites this paper
• Urotensin-II in the lung: A matter for vascular remodelling and pulmonary hypertension?

  2007cites this paper
• Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.

  2006cites this paper
• Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome: A Preliminary Observational Study

  2006cites this paper
• Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond

  2006cites this paper
• Sildenafil for pulmonary arterial hypertension: when blue turns into white

  2006cites this paper
• Sleeping Beauty‐mediated eNOS gene therapy attenuates monocrotaline‐induced pulmonary hypertension in rats

  2006cites this paper
• CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway

  2005cites this paper
• Sildenafil citrate therapy for pulmonary arterial hypertension.

  2005cites this paper
• Cardiopulmonary Effects of Chronic Administration of the NO Synthase Inhibitor L-NAME in the Chick Embryo

  2005cites this paper
• Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.

  2005cites this paper
• Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors.

  2005cites this paper
• Erectile dysfunction: pathophysiologic mechanisms pointing to underlying cardiovascular disease.

  2005cites this paper
• Pulmonary vascular dilation induced by l‐arginine: correlation with induction of endothelial nitric oxide synthase in a rabbit model

  2005influential citation
• Cytokine-induced endothelial arginase expression is dependent on epidermal growth factor receptor.

  2005cites this paper
• Excess l-arginine restores endothelium-dependent relaxation impaired by monocrotaline pyrrole.

  2005cites this paper
• Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension.

  2005cites this paper
• Sildenafil in pulmonary hypertension.

  2005cites this paper
• Nitric Oxide as a Unique Bioactive Signaling Messenger in Physiology and Pathophysiology

  2004cites this paper
• Sildenafil, Nitric Oxide, and Acute Lung Injury: Pathophysiology Beats Pharmacotherapy?

  2004cites this paper
• Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.

  2004cites this paper
• Extended colonic ulcerations in a patient with microscopic polyangiitis

  2004cites this paper
• Normal pulmonary capillary blood volume in patients with chronic infiltrative lung disease and high pulmonary artery pressure.

  2004cites this paper
• Phosphodiesterase Inhibitors and Persistent Pulmonary Hypertension of the Newborn

  2004influential citation
• Ruthenium as an effective nitric oxide scavenger.

  2004cites this paper
• Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

  2003cites this paper
• Aldosterone Inactivates the Endothelin-b Receptor via a Cysteinyl Thiol Redox Switch to Decrease Pulmonary Endothelial Nitric Oxide Levels and Modulate Pulmonary Arterial Hypertension Running Title: Maron Et Al.; Aldosterone Promotes Pulmonary Arterial Hypertension

  year unknowncites this paper